Documents
Application Sponsors
ANDA 215834 | LOTUS PHARM CO LTD | |
Marketing Status
None (Tentative Approval) | 001 |
Application Products
001 | CAPSULE;ORAL | 25MG | 0 | MIDOSTAURIN | MIDOSTAURIN |
FDA Submissions
UNKNOWN; | ORIG | 1 | TA | 2022-08-24 | STANDARD |
Submissions Property Types
CDER Filings
LOTUS PHARM CO LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 215834
[companyName] => LOTUS PHARM CO LTD
[docInserts] => ["",""]
[products] => [{"drugName":"MIDOSTAURIN","activeIngredients":"MIDOSTAURIN","strength":"25MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"08\/24\/2022","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2022-08-24
)
)